Viewing Study NCT01165502

Home

Certify Doc

Genes

Clinical Trials

CompTox

DrugMatrix

Open Targets

Products

Support

Bugs

Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug

Ignite Creation Date: 2025-12-25 @ 3:52 AM

Ignite Modification Date: 2025-12-26 @ 2:41 AM

Study NCT ID: NCT01165502

Status: COMPLETED

Last Update Posted: 2011-01-19

First Post: 2010-07-16

Is NOT Gene Therapy: False

Has Adverse Events: False

Brief Title: Clinical Study to Investigate Safety and Tolerability and Pharmacokinetics of Multiple Ascending Doses of CM3.1-AC100 in Healthy Male Volunteers

Sponsor: CellMed AG, a subsidiary of BTG plc.

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module